BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 15206967)

  • 1. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tacrolimus for parastomal pyoderma gangrenosum: a report of two cases.
    Altieri M; Vaziri K; Orkin BA
    Ostomy Wound Manage; 2010 Sep; 56(9):56-9. PubMed ID: 20855912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tacrolimus in the management of peristomal pyoderma gangrenosum.
    Lyon CC; Stapleton M; Smith AJ; Mendelsohn S; Beck MH; Griffiths CE
    J Dermatolog Treat; 2001 Mar; 12(1):13-7. PubMed ID: 12171681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum.
    Deckers-Kocken JM; Pasmans SG
    Arch Dis Child; 2005 May; 90(5):531. PubMed ID: 15851442
    [No Abstract]   [Full Text] [Related]  

  • 5. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parastomal pyoderma gangrenosum: clinical features and management.
    Lyon CC; Smith AJ; Beck MH; Wong GA; Griffiths CE
    J Am Acad Dermatol; 2000 Jun; 42(6):992-1002. PubMed ID: 10827402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum.
    Marzano AV; Trevisan V; Lazzari R; Crosti C
    J Dermatolog Treat; 2010 May; 21(3):140-3. PubMed ID: 19903010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penile pyoderma gangrenosum treated with topical tacrolimus.
    Lally A; Hollowood K; Bunker CB; Turner R
    Arch Dermatol; 2005 Sep; 141(9):1175-6. PubMed ID: 16172330
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pyoderma gangrenosum--positive effect of cyclosporin A therapy ].
    Krauze E; Lis A; Kamińska-Budzińska G; Wygledowska-Kania M; Pierzchała E; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Oct; 13(76):336-40. PubMed ID: 12557445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ; Gangaram HB; Hussein SH
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
    Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Management of Peristomal Pyoderma Gangrenosum in IBD.
    O'Brien SJ; Ellis CT
    Dis Colon Rectum; 2020 Jul; 63(7):881-884. PubMed ID: 32496328
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus for pyoderma gangrenosum: Another report.
    Piccirillo A; Ricciuti F
    J Dermatol; 2006 Mar; 33(3):232. PubMed ID: 16620236
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.
    Bellini V; Simonetti S; Lisi P
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):113-5. PubMed ID: 18181988
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
    Handler MZ; Hamilton H; Aires D
    J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506)].
    Petering H; Kiehl P; Breuer C; Kapp A; Werfel T
    Hautarzt; 2001 Jan; 52(1):47-50. PubMed ID: 11220239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of peristomal pyoderma gangrenosum.
    Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
    Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.